CDKN2BAS has also been declared to be involved in brain tumor, breast cancer, and medulloblastoma [21–23]; however, the biological function of CDKN2BAS in HCC remains unclear. This evidence concerns the gene CDKN2B-AS1 and breast carcinoma.